ICM
ENOV icon

Invenomic Capital Management’s Enovis ENOV Stock Holding History

Invenomic Capital Management’s Portfolio ENOV Stock Details ENOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16M Sell
772,034
-131,428
-15% -$3.1M 0.95% 37
2026
Q1 		$20.6M Buy
903,462
+146,745
+19% +$3.47M 0.94% 39
2025
Q4 		$20.2M Buy
756,717
+44,048
+6% +$1.3M 0.94% 34
2025
Q3 		$21.6M Buy
712,669
+131,705
+23% +$3.99M 1.05% 30
2025
Q2 		$18.2M Buy
580,964
+131,187
+29% +$4.34M 1.03% 32
2025
Q1 		$17.2M Buy
449,777
+299,658
+200% +$12.7M 0.87% 35
2024
Q4 		$6.59M Buy
+150,119
New +$6.59M 0.31% 99

Other funds holding ENOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Invenomic Capital Management's ENOV Position: Q2 2026 in Review

Invenomic Capital Management reduced its Enovis (ENOV) stake by 15% in Q2 2026, selling an estimated $3.1M and leaving 772,034 shares worth $16M. The position accounts for 0.95% of the portfolio, ranked #37.

Invenomic Capital Management first reported a position in ENOV in Q4 2024 and has held it in 7 quarters since. The position peaked at $21.6M in Q3 2025. 253 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Invenomic Capital Management held 772,034 shares of Enovis worth $16M as of Q2 2026.
  • Invenomic Capital Management sold 131,428 Enovis shares in Q2 2026, an estimated $3.1M.
  • Enovis made up 0.95% of Invenomic Capital Management's portfolio in Q2 2026, its #37 holding.
  • Invenomic Capital Management first reported a position in Enovis in Q4 2024 and has held it in 7 quarters since.
  • Invenomic Capital Management's Enovis position peaked at $21.6M in Q3 2025.
  • 253 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.